AGX 1009
Alternative Names: AGX-1009; Tenofovir ODELatest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator Chinese Academy of Medical Sciences
- Developer Agenix
- Class Phosphonic acids; Purines; Small molecules
- Mechanism of Action Nucleotide reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis B